Mark Lupher Jr. - 07 Feb 2024 Form 4 Insider Report for Adverum Biotechnologies, Inc. (ADVM)

Role
Director
Signature
/s/ Peter Soparkar, Attorney-in-Fact
Issuer symbol
ADVM
Transactions as of
07 Feb 2024
Transactions value $
$175,500
Form type
4
Filing time
09 Feb 2024, 17:50:28
Previous filing
13 Jun 2023
Next filing
20 Jun 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADVM Common Stock Purchase $176K +130K $1.35 130K 07 Feb 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of the Issuer's common stock were purchased in the Issuer's private placement of common stock pursuant to a Securities Purchase Agreement, dated February 5, 2024, by and among the Issuer and the other purchaser named therein. The shares of common stock acquired were purchased at a price per share of $1.35.
F2 The shares are held by a traditional IRA for the benefit of the Reporting Person.